INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
How Real-World Data On Site Costs Accelerates Clinical Trial Success
Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
-
Unlocking The Benefits Of Site Payment Platforms: Part 1
By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.
-
eCOA Standards And KPIs To Include In Your Next RFI
Check out this practical roadmap on vendor selection and learn specific performance metrics and quality benchmarks you should ask your next eCOA partner.
-
Why AI Matters In Early Phase Clinical Trials3/11/2026
AI speeds early‑phase development by streamlining data review, enabling structured queries, accelerating PK/PD work, and revealing biomarker patterns — boosting efficiency with expert oversight.
-
FAQs About Patient Payments Technology For Clinical Trials9/4/2026
Answers to common questions about simplifying participant reimbursement, reducing site admin work, and improving retention through faster clinical trial payments.
-
Improving Site Efficiency With Automated Drug Resupply And Forecasting8/22/2025
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Turning Innovation Into Execution In CNS Trials2/24/2026
SCOPE 2026 experts called for practical planning, iterative testing, and real‑world workflows in mental health research, highlighting mock visits, expanded roles, engagement, and psychedelic safety.
-
Breaking Barriers: Enhancing The Bioavailability Of Orally Delivered TPDs10/20/2025
The large, bulky structure of TPDs limits solubility and permeability. Enabling technologies like spray drying, hot melt extrusion, and nanomilling are key to formulating these challenging molecules.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Uncover how we're able to bring integrated services and trusted scientific insight to every molecule and program.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
People-focused, detail-driven (and award-winning!) support for participants, sites, and sponsors.
Scout’s patient concierge team manages payments, travel, and scheduling with precision and empathy—helping sites save time, build trust, and reduce dropouts.
-
Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.
-
Plan face-to-face, virtual, and hybrid life sciences events with precision using an end-to-end service that plans everything from investigator meetings to advisory boards and incentive trips.